Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
401.75
+4.27 (1.07%)
Nov 21, 2024, 2:04 PM EST - Market open
Elevance Health Analyst Ratings
Total Analysts
14
Consensus Rating
Strong Buy
Price Target
$543.07
Upside
+35.18%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Maintains $585 → $505 | Buy | Maintains | $585 → $505 | +25.70% | Nov 5, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $593 → $495 | Buy | Maintains | $593 → $495 | +23.21% | Nov 4, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $643 → $551 | Buy | Maintains | $643 → $551 | +37.15% | Oct 23, 2024 |
| Barclays | Barclays | Buy Maintains $622 → $501 | Buy | Maintains | $622 → $501 | +24.70% | Oct 22, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $589 → $484 | Strong Buy | Maintains | $589 → $484 | +20.47% | Oct 21, 2024 |
| UBS | UBS | Strong Buy Maintains $605 → $555 | Strong Buy | Maintains | $605 → $555 | +38.15% | Oct 18, 2024 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $620 → $520 | Strong Buy | Reiterates | $620 → $520 | +29.43% | Oct 18, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $585 → $478 | Buy | Maintains | $585 → $478 | +18.98% | Oct 18, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $600 → $485 | Buy | Maintains | $600 → $485 | +20.72% | Oct 18, 2024 |
| Barclays | Barclays | Buy Maintains $611 → $622 | Buy | Maintains | $611 → $622 | +54.82% | Oct 10, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $600 | Buy | Reiterates | $600 | +49.35% | Oct 1, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $600 | Buy | Reiterates | $600 | +49.35% | Sep 20, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $600 | Buy | Reiterates | $600 | +49.35% | Sep 10, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $615 | Buy | Reiterates | $615 | +53.08% | Sep 5, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $600 | Buy | Reiterates | $600 | +49.35% | Aug 19, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $600 | Buy | Reiterates | $600 | +49.35% | Jul 23, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.